scholarly article | Q13442814 |
P50 | author | Stephen B. Baylin | Q28113000 |
Steven A Belinsky | Q96685352 | ||
P2093 | author name string | Mathewos Tessema | |
Kornel E Schuebel | |||
Christine A Stidley | |||
Emi O Machida | |||
Yang Y Yu | |||
P2860 | cites work | Double strand breaks can initiate gene silencing and SIRT1-dependent onset of DNA methylation in an exogenous promoter CpG island | Q21092482 |
DNA damage, homology-directed repair, and DNA methylation | Q21092492 | ||
Two genetic hits (more or less) to cancer | Q22251289 | ||
Lung cancer incidence in never smokers | Q23913478 | ||
Human BOULE gene rescues meiotic defects in infertile flies | Q24337619 | ||
HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. | Q24541580 | ||
Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer | Q24550887 | ||
Somatic mutations affect key pathways in lung adenocarcinoma | Q24648102 | ||
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma | Q24651026 | ||
Global cancer statistics, 2002 | Q27860562 | ||
The consensus coding sequences of human breast and colorectal cancers | Q27861035 | ||
Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines | Q28202433 | ||
Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer | Q28204269 | ||
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers | Q28214439 | ||
Correlation between insulin-like growth factor-binding protein-3 promoter methylation and prognosis of patients with stage I non-small cell lung cancer | Q28217003 | ||
Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types | Q28248276 | ||
Lung cancer in never smokers: a review | Q28287500 | ||
The epigenomics of cancer | Q28289975 | ||
Aberrant methylation of Reprimo in human malignancies | Q28306530 | ||
Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis | Q28472991 | ||
Lung cancer in never smokers--a different disease | Q29615414 | ||
Comparing the DNA hypermethylome with gene mutations in human colorectal cancer | Q33300134 | ||
The new World Health Organization classification of lung tumours | Q34112802 | ||
Association of meiotic arrest with lack of BOULE protein expression in infertile men. | Q34311879 | ||
Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers | Q34351025 | ||
Association of three isoforms of the meiotic BOULE gene with spermatogenic failure in infertile men. | Q34582805 | ||
Aberrant promoter methylation of p16 and MGMT genes in lung tumors from smoking and never-smoking lung cancer patients | Q35060286 | ||
Gene-promoter hypermethylation as a biomarker in lung cancer | Q35877182 | ||
Double-strand break damage and associated DNA repair genes predispose smokers to gene methylation | Q36790428 | ||
Carcinogen-induced gene promoter hypermethylation is mediated by DNMT1 and causal for transformation of immortalized bronchial epithelial cells | Q39923075 | ||
Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. | Q40002585 | ||
Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors | Q40213076 | ||
Mechanisms underlying lack of insulin-like growth factor-binding protein-3 expression in non-small-cell lung cancer. | Q40536844 | ||
Aberrant promoter methylation of the transcription factor genes PAX5 alpha and beta in human cancers. | Q44542352 | ||
Aberrant methylation of Reprimo in lung cancer | Q45267063 | ||
Multiplicity of abnormal promoter methylation in lung adenocarcinomas from smokers and never smokers | Q47885434 | ||
Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression. | Q51657031 | ||
Lung cancer death rates in lifelong nonsmokers. | Q51804779 | ||
Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band. | Q53346861 | ||
CHFR expression is preferentially impaired in smoking-related squamous cell carcinoma of the lung, and the diminished expression significantly harms outcomes. | Q53466648 | ||
Mutational and Epigenetic Evidence for Independent Pathways for Lung Adenocarcinomas Arising in Smokers and Never Smokers | Q57918851 | ||
Lung cancer, smoke exposure, and sex | Q79750593 | ||
Synchronous alterations of Wnt and epidermal growth factor receptor signaling pathways through aberrant methylation and mutation in non small cell lung cancer | Q81463886 | ||
Identification of 20 genes aberrantly methylated in human breast cancers | Q81629206 | ||
Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort | Q82843914 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | adenocarcinoma | Q356033 |
P304 | page(s) | 1132-8 | |
P577 | publication date | 2009-07-01 | |
P1433 | published in | Carcinogenesis | Q326022 |
P1476 | title | Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers | |
P478 | volume | 30 |
Q36803539 | A three-gene signature as potential predictive biomarker for irinotecan sensitivity in gastric cancer |
Q64983051 | Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. |
Q37214386 | Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model |
Q35233697 | Ambient PM exposure and DNA methylation in tumor suppressor genes: a cross-sectional study |
Q36340108 | Biomarkers and the genetics of early neoplastic lesions |
Q37633163 | CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer. |
Q34103461 | Cigarette smoking and p16INK4α gene promoter hypermethylation in non-small cell lung carcinoma patients: a meta-analysis |
Q39609163 | Combination therapy with vidaza and entinostat suppresses tumor growth and reprograms the epigenome in an orthotopic lung cancer model |
Q28304465 | Correlation between the methylation of SULF2 and WRN promoter and the irinotecan chemosensitivity in gastric cancer |
Q37642982 | DNA methylation at modifier genes of lung disease severity is altered in cystic fibrosis. |
Q38018995 | DNA methylation biomarkers in cancer: progress towards clinical implementation |
Q39418597 | DNA methylation of the CYP1A1 enhancer is associated with smoking-induced genetic alterations in human lung. |
Q64387061 | DNA-PKc deficiency drives pre-malignant transformation by reducing DNA repair capacity in concert with reprogramming the epigenome in human bronchial epithelial cells |
Q36355560 | Defining a gene promoter methylation signature in sputum for lung cancer risk assessment |
Q35880987 | Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer |
Q39373653 | Epigenetic therapy of non-small cell lung cancer using decitabine (5-aza-2'-deoxycytidine). |
Q26996766 | Epigenetics of lung cancer |
Q64120284 | Exposure to polycyclic aromatic hydrocarbons derived from vehicle exhaust gas induces premature senescence in mouse lung fibroblast cells |
Q34044005 | GATA2 is epigenetically repressed in human and mouse lung tumors and is not requisite for survival of KRAS mutant lung cancer |
Q39366723 | Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays. |
Q37855515 | Genetic and epigenetic changes in lung carcinoma and their clinical implications |
Q45906493 | Genome-wide CpG island methylation analyses in non-small cell lung cancer patients. |
Q42270103 | Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer |
Q33947935 | Genome-wide unmasking of epigenetically silenced genes in lung adenocarcinoma from smokers and never smokers |
Q54381660 | Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer. |
Q34216446 | HIF1α regulated expression of XPA contributes to cisplatin resistance in lung cancer |
Q37485675 | Increased methylation of lung cancer-associated genes in sputum DNA of former smokers with chronic mucous hypersecretion |
Q36464478 | Maternal smoking as a model for environmental epigenetic changes affecting birthweight and fetal programming |
Q35160337 | Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients |
Q36189699 | Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma |
Q36182205 | Methylated Genes in Sputum Among Older Smokers With Asthma. |
Q39064248 | MicroRNA-143 is downregulated in breast cancer and regulates DNA methyltransferases 3A in breast cancer cells. |
Q52974103 | Oncogenic Role of BOLL in Colorectal Cancer. |
Q35761818 | Particulate matter Air Pollution induces hypermethylation of the p16 promoter Via a mitochondrial ROS-JNK-DNMT1 pathway |
Q34134446 | Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosis |
Q39007185 | Regulatory roles of epigenetic modulators, modifiers and mediators in lung cancer |
Q35840419 | SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15. |
Q37432727 | Smoking and microRNA dysregulation: a cancerous combination |
Q57804585 | Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer |
Q38500320 | Targeting of cancer stem cells by inhibitors of DNA and histone methylation. |
Q34762265 | The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas |
Search more.